Intimal hyperplasia in human uterine arteries accompanied by impaired synergism between prostaglandin I2 and nitric oxide

British Journal of Pharmacology

Volumn 119, Issue 5, 1996, Pages 1072-1078

  Obayashi, Satoshi ^a   Aso, Takeshi ^a   Sato, Jun ^b   Hamasaki, Hidehisa ^b   Azuma, Hiroshi ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cyclic AMP; Cyclic GMP; Human uterine artery; Intimal hyperplasia; Synergism between PGI2 and NO

Indexed keywords

CYCLIC AMP; CYCLIC GMP; ELASTIN; ILOPROST; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN;

ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; UTERINE ARTERY;

EID: 0029860286     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15779.x     Document Type: Article

References (35)

1. ALLAIN, C.C. (1974). Enzymatic determination of total serum cholesterol. Clin. Chem., 20, 470-475.
2. ANFOSSI, G., MASSUCCO, P., MULARONI, E., CAVALOT, F., MATTIELLO, L. & TROVATI, M. (1993). Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost. Prostaglandins Leukot. Essent. Fatty Acids, 49, 839-845.
3. AZUMA, H., FUNAYAMA, N., KUBOTA, T. & ISHIKAWA, M. (1990). Regeneration of endothelial cells after balloon denudation of the rabbit carotid artery and changes in responsiveness. Jpn. J. Pharmacol., 52, 541-552.
4. AZUMA, H., ISHIKAWA, M. & SEKIZAKI, S. (1986). Endothelium-dependent inhibition of platelet aggregation. Br. J. Pharmacol., 88, 411-415.
5. AZUMA, H., NIIMI, Y. & HAMASAKI, H. (1992). Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan. Br. J. Pharmacol., 106, 665-671.
6. AZUMA, H., NIIMI, Y., TERADA, T. & HAMASAKI, H. (1995a). Accelerated endothelial regeneration and intimal hyperplasia following a repeat denudation of rabbit carotid arteries-Morphological and immunohistochemical studies. Clin. Exp. Pharmacol. Physiol., 22, 748-754.
7. AZUMA, H., OBAYASHI, S., HAMASAKI, H., KOYAMA, T & ASO, T. (1995b). Role of endothelium in the human uterine arteries during normal menstrual cycle. Br. J. Pharmacol., 114, 902-908.
8. 1. J. Cardiovasc. Pharmacol., 17, 424-433.
9. DE WIT, C., VON BISMARCK, P. & POHL, U. (1994). Synergistic action of vasodilators that increase cGMP and cAMP on the hamster cremaster microcirculation. Cardiovasc. Res., 28, 1513-1518.
10. FLETCHER, M.J. (1968). Colorimetric method for estimation of serum triglycerides. Clin. Chem. Acta, 22, 393-397.
11. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
12. GARG, U.C. & HASSID, A. (1989). Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest., 83, 1774-1777.
13. HONMA, M., SATOH, T., TAKEZAWA, J. & Ul, M. (1977). An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem. Med., 18, 257-273.
14. IGNARRO, R.J. (1989). Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res., 65, 1-21.
15. JANG, E.K., DAVIDSON, M.M.L., CRANKSHAW, D. & HASLAM, R.J. (1993). Synergistic inhibitory effects of atriopeptin II and isoproterenol on contraction of rat aortic smooth muscle: roles of cGMP and cAMP. Eur. J. Pharmacol., 28, 1513-1518.
16. KOBAYASHI, Y. & HATTORI, K. (1990). Nitroarginine inhibits endothelium-derived relaxation. Jpn. J. Pharmacol., 52, 167-169.
17. KOWULAK, E.A., SETH, P. & FUNG, H. (1992). Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J. Pharmacol. Exp. Ther., 262, 916-922.
18. LEVIN, R.I., WEKSLER, B.B. & JAFFE, E.A. (1982). The interaction of sodium nitroprusside and prostacyclin with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function. Circulation, 66, 1299-1307.
19. 2 receptor antagonist, daltroban, in experimental intimal hyperplasia. Prostaglandins, 41, 1-6.
20. LU, J.K.H., GILMAN, D.P., MELDRUM, D.R., JUDD, H.L. & SAWYER, C.H. (1981). Relationship between circulating estrogens and the central mechanisms by which ovarian steroids stimulate luteinizing hormone secretion in aged and young female rats. Endocrinology., 108, 836-841.
21. MAURICE, D.H., CRANSHAW, D. & HASLAM, R.J. (1991). Synergistic actions of nitrosodilators and isoprenaline on rat aortic smooth muscle. Eur. J. Pharmacol., 192, 235-242.
22. 2 and prostacyclin. Pharmacol. Rev., 30, 293-331.
23. 2 in cultured rabbit aortic smooth muscle cells. Atherosclerosis, 71, 165-171.
24. NEWGREEN, D.T., BRAY, K.M., MCHARG, A.D., WESTON, A.H., DUTY, S., BROWN, B.S., KAY, P.B., EDWARDS, G., LONGMORE, J. & SOUTHERTON, P.B. (1990). The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Br. J. Pharmacol., 100, 605 613.
25. NIIMI, Y., AZUMA, H. & HIRAKAWA, K. (1994). Repeated endothelial removal augments intimal thickening and attenuates EDRF release. Am. J. Physiol., 266, (Heart Circ. Physiol., 35), H1348-H1365.
26. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1987). The antiaggregating properties of vascular endothelium interaction between prostacyclin and nitric oxide. Br. J. Pharmacol., 92, 639-646.
27. RAPOPORT, R.M. & MURAD, F. (1983). Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ. Res., 52, 352-357.
28. ROSS, R. (1986). The pathogenesis of atherosclerosis an update. N. Engl. J. Med., 314, 488-500.
29. SCHWARTZ, S.M., GAJDUSEK, C.M. & SELDEN, S.C. (1981). Vascular wall growth control: the role of the endothelium. Arteriosclerosis, 1, 106-171.
30. SNOW, A.D., BOLENDER, R.P., WIGHT, T.N. & CLOWES, A.W. (1990). Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am. J. Pathol., 137, 313-330.
31. STOUT, R.W. (1982). Cyclic AMP: a potent inhibitor of DNA synthesis in cultured arterial endothelial and smooth muscle cells. Diabetology., 22, 51-55.
32. STRAUSS, B.H., CHISHOLM, R.J., KEELEY, F.W., GOTLIEB, A.L., LOGAN, R.A. & ARMSTRONG, P.W. (1994). Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ. Res., 75, 650-658.
33. SWEDBERG, S.H., BROWN, B.G., SIGLEY, R., WRIGHT, T.N., GORDON, D. & NICHOLLS, S.C. (1989). Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE graft in hemodialysis patients: clinical, immunohistochemical, light and electron microscopic assessment. Circulation, 80, 1726-1736.
34. TSUJII, T., AZUMA, H., YAMAGUCHI, T. & OSHIMA, H. (1992). A possible role of decreased relaxation mediated by β-adrenoceptors in bladder outlet obstruction by benign prostatic hyperplasia. Br. J. Pharmacol., 107, 803-807.
35. UEHARA, Y., ISHIMIZU, T., KIMURA, K., ISHII, M., IKEDA, T. & SUGIMOTO, T. (1988). Regulatory effects of eicosanoids on thymidine uptake by vascular smooth muscle cells of rats. Prostaglandins, 36, 847-857.